Matthew McLaughlin v. HHS - HPV, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (2016)

Matthew McLaughlin filed a petition on March 17, 2016, alleging that he developed Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) as a result of receiving the hepatitis A, Menactra, and HPV vaccines on or about May 2, 2012. He further alleged that he experienced residual effects from this injury for more than six months.

The respondent, the Secretary of Health and Human Services, denied that the vaccines caused Mr. McLaughlin's CIDP or any other injury.

Despite the respondent's denial, the parties reached a settlement through a stipulation, which was filed on March 17, 2016. Special Master Laura D.

Millman reviewed the stipulation and found its terms to be reasonable. The court adopted the stipulation and awarded Mr.

McLaughlin $175,000.00 as compensation for all damages. The award was to be paid as a lump sum check made payable to the petitioner.

The decision was issued on March 17, 2016. Petitioner's counsel was Jeffrey S.

Pop, and respondent's counsel was Gordon Shemin. The public decision does not describe the onset of symptoms, specific clinical details, diagnostic tests, treatments, or the mechanism of causation.